Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00350571 · ClinicalTrials.gov registry record · Phase 1

Brief Interventions for Drop-out Re-engagement

A Phase 1 study, sponsored by Yale University.

Completed
Registry status
Phase 1
Development phase
299
Enrollment target

NCT00350571: Completed Phase 1 study, sponsored by Yale University.

NCT00350571 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 299 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (398% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00350571, a Phase 1 study, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 1
Development phase
299 participants
Enrollment target

Study Summary

We will evaluate a series of interventions intended to help individuals who drop out of substance abuse treatment re-engage in order to improve treatment outcome.

Interventions

  • BEHAVIORAL brief (behavioral therapy)
  • BEHAVIORAL Drop out re-engagement motivational intervention
  • BEHAVIORAL standard care follow up

Trial Details

FieldValue
Enrollment Target 299 participants
Start Date 2004-11
Est. Completion 2009-11
Phase Phase 1
Yale University

1,492 total trials

What the finished NCT00350571 record still lists

NCT00350571 is an interventional study that assigns participants to a tested intervention. The registered 299 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (398% higher).

The record links to 0 conditions, and to 3 interventions - of which brief (behavioral therapy) is the first listed.

NCT00350571 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00350571 about?

NCT00350571 is a clinical study titled "Brief Interventions for Drop-out Re-engagement". We will evaluate a series of interventions intended to help individuals who drop out of substance abuse treatment re-engage in order to improve treatment outcome.

What is the current status of trial NCT00350571?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 299 participants. The study started on 2004-11. Estimated completion is 2009-11.

What interventions are being tested in trial NCT00350571?

The interventions under investigation include: brief (behavioral therapy) (BEHAVIORAL), Drop out re-engagement motivational intervention (BEHAVIORAL), standard care follow up (BEHAVIORAL).

Who is sponsoring clinical trial NCT00350571?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00350571's enrollment target sits among peer trials

299 134th of 2000 higher than 1,867 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00350571, the US trial registry maintained by the National Library of Medicine. NCT00350571 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.